Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

February 19, 2024 13:52 (London Time)

Gilead Sciences

Youtube Subscribe

...

Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9451
MarketCap: 89,179,218,425.0
High: 73.09 Low: 71.37

Open: 73.0 Close: 71.58 Change: -1.42

Stop reading the whole internet to decide if you want to invest in Gilead Sciences Company Inc.

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, disease, buy, CymaBay, liver, and the most common words in the summary are: gilead, science, best, stock, news, inc, cymabay, . One of the sentences in the summary was: Food and Drug Administration has put a hold on trials testing …

Concept Map

...

Semantic Network

...

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion. Food and Drug Administration has put a hold on trials testing Gileads blood cancer drug Trodelvy. FDA has put hold on clinical trials testing the drug.

Today's News

gilead sciences ‘strengthens commitment to inflammatory disease with new research site. Gilead Sciences has been named one of one Newsweek Greatest Workplaces for Diversity. Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion. The company is buying the developer of medicine for liver and other chronic diseases. Gilead Sciences Inc. is known for its innovative therapies in areas such as HIV, oncology, and liver diseases. Food and Drug Administration (FDA) has put a hold on trials testing Gileads blood cancer drug Trodelvy. The report will provide a comprehensive analysis of the companys financial performance and recent news developments. Gilead Sciences has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead Sciences has agreed to acquire CymaBay Therapeutics for $4.3 billion. CymaBays lead candidate seladelpar indicated to treat primary biliary cholangitis (PBC) Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, develops and commercializes innovative therapeutics in areas of unmet medical need. The company is in the Health Care sector and Biotechnology industry.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, disease, buy, CymaBay, liver, and the most common words in the summary are: gilead, science, best, stock, news, inc, cymabay, . One of the sentences in the summary was: Food and Drug Administration has put a hold on trials testing Gileads blood cancer drug Trodelvy. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #best #stock #news #inc #cymabay.

Read more →

Related Results

...
March 09, 2024 15:48 (London Time)

Gilead Sciences

Gilead Sciences has one of the strongest and most diverse pipelines of new medicines in its history. The expansion of Gileads into cancer medicines …
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8779
MarketCap: 93,582,589,153.0
High: 75.44 Low: 73.66

Open: 73.96 Close: 75.12 Change: 1.16

Read more →
...
February 24, 2024 23:09 (London Time)

Gilead Sciences

Gilead Sciences has paused enrolment in the magrolimab solid tumour trials, with the FDA requesting a partial clinical hold on these studies. Gilead…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9477
MarketCap: 91,646,381,377.0
High: 74.24 Low: 73.0

Open: 73.25 Close: 73.55 Change: 0.3

Read more →
...
January 31, 2024 14:33 (London Time)

Gilead Sciences

Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on February 6, 2024. Company raises stake in cancer-centric Arcus Biosc…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8979
MarketCap: 97,963,813,784.0
High: 78.9 Low: 77.96

Open: 78.8 Close: 78.62 Change: -0.18

Read more →
...
December 02, 2023 5:26 (London Time)

Gilead Sciences

Gilead Sciences has on average historically risen by 24% based on the past 31 years of stock performance. The score for GILD is 63, which is 26% abo…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.0258
MarketCap: 96,755,153,146.0
High: 77.66 Low: 76.2

Open: 76.78 Close: 77.65 Change: 0.87

Read more →
...
November 09, 2023 21:53 (London Time)

Gilead Sciences

Gilead Sciences posted better-than-expected top- and bottom-line results in the latest quarter. Biopharmaceutical company credits its virology and o…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9382
MarketCap: 97,066,663,620.0
High: 77.71 Low: 74.73

Open: 77.53 Close: 74.98 Change: -2.55

Read more →
...
October 27, 2023 16:05 (London Time)

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certai…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8402
MarketCap: 97,824,586,854.0
High: 78.5 Low: 77.16

Open: 78.39 Close: 77.44 Change: -0.95

Read more →
...
October 16, 2023 3:01 (London Time)

Gilead Sciences

Gilead Sciences Inc. stock outperforms market on strong trading day - marketwatch.com.com. Gileade Sciences stock was originally listed at a price o…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9661
MarketCap: 96,753,014,510.0
High: 77.86 Low: 76.97

Open: 77.19 Close: 77.65 Change: 0.46

Read more →
...
October 05, 2023 22:28 (London Time)

Gilead Sciences

Gilead Sciences has outperformed the S&P 500 with a 19% return since August last year. Geoff Meacheram has given his Buy rating to Gileads due to se…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9501
MarketCap: 93,127,112,743.0
High: 75.03 Low: 74.15

Open: 74.67 Close: 74.7 Change: 0.03

Read more →
...
September 06, 2023 22:12 (London Time)

Gilead Sciences

Gilead Sciences Inc. has on average historically risen by 32% based on the past 31 years of stock performance. Over 20 individual plaintiffs recentl…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8625
MarketCap: 93,650,438,771.0
High: 75.14 Low: 73.25

Open: 75.12 Close: 74.24 Change: -0.88

Read more →
...
August 24, 2023 9:46 (London Time)

Gilead Sciences

Gilead Sciences has an advanced drug discovery and commercialisation pipeline across HIV, cancer, and inflammation, among other areas. Analyst Conse…
Sector: Biotechnology
Ticker: GILD
Sentiment: -0.8679
MarketCap: 95,992,945,755.0
High: 78.98 Low: 76.96

Open: 78.3 Close: 77.04 Change: -1.26

Read more →
...
August 10, 2023 15:39 (London Time)

Gilead Sciences

Gilead Sciences reported lower second-quarter profit due to a drop in sales of the companys Veklury antiviral and a $525 million legal settlement. C…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.3818
MarketCap: 99,892,970,680.0
High: 81.09 Low: 80.38

Open: 80.38 Close: 80.86 Change: 0.49

Read more →
...
July 16, 2023 12:27 (London Time)

Gilead Sciences

Gilead Sciences (GILD) closed at $76.72 in the latest trading session, marking a +0.43% move from the previous day. FDA approved Gileads Remdesivir …
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9186
MarketCap: 96,283,154,063.0
High: 77.64 Low: 76.46

Open: 76.61 Close: 77.19 Change: 0.58

Read more →
...
June 28, 2023 12:23 (London Time)

Gilead Sciences

Gilead Sciences closed the most recent trading day at $76.56, moving -1.17% from the previous trading session. Wall Street analysts forecast GILD st…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8957
MarketCap: 95,497,321,869.0
High: 76.89 Low: 75.8

Open: 76.65 Close: 76.01 Change: -0.64

Read more →
...
June 03, 2023 17:53 (London Time)

Gilead Sciences

Zacks Research decreased their Q1 2024 earnings per share estimates for shares of Gilead Sciences in a note issued to investors on Wednesday, May 31…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.961
MarketCap: 97,992,960,000.0
High: 77.99 Low: 75.8

Open: 76.12 Close: 77.89 Change: 1.77

Read more →
...
May 28, 2023 20:18 (London Time)

Gilead Sciences

Gilead Sciences acquisition of XinThera is a strategic move to strengthen its early pipeline in oncology and inflammation. Motco increased its holdi…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8979
MarketCap: 97,992,960,000.0
High: 78.62 Low: 77.01

Open: 78.0 Close: 77.09 Change: -0.91

Read more →
...
March 02, 2024 14:24 (London Time)

Gilead Sciences

Gilead Sciences has on average historically risen by 22.5% based on the past 32 years of stock performance. CymaBay Therapeutics shares jumped nearl…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9682
MarketCap: 90,057,046,990.0
High: 72.66 Low: 72.04

Open: 72.28 Close: 72.31 Change: 0.03

Read more →
...
February 19, 2024 13:52 (London Time)

Gilead Sciences

Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion. Food and Drug Administration has put a hold on trials testing Gileads blood cancer …
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9451
MarketCap: 89,179,218,425.0
High: 73.09 Low: 71.37

Open: 73.0 Close: 71.58 Change: -1.42

Read more →
...
January 09, 2024 10:14 (London Time)

Gilead Sciences

Gilead Sciences Inc. (Gild) stock climbed 2% in extended trading Tuesday after the pharmaceutical company reported quarterly results that topped ana…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9851
MarketCap: 104,642,598,342.0
High: 84.07 Low: 82.5

Open: 82.86 Close: 83.99 Change: 1.13

Read more →
...
November 16, 2023 20:40 (London Time)

Gilead Sciences

Walletinvestor.com predicts future values with technical analysis for wide selection of stocks like Gilead Sciences, Inc. The GILD (GILD ) future st…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.975
MarketCap: 93,527,904,638.0
High: 76.15 Low: 73.99

Open: 75.53 Close: 74.35 Change: -1.18

Read more →
...
November 05, 2023 11:56 (London Time)

Gilead Sciences

Gilead Sciences stock quote is 81.59 USD today. Current trend is considered strongly bullish and GILD is experiencing selling pressure, which indica…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8519
MarketCap: 101,662,311,061.0
High: 82.59 Low: 81.51

Open: 82.0 Close: 81.59 Change: -0.41

Read more →
...
October 26, 2023 4:39 (London Time)

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that researches, develops, sells and sells therapies for treating HIV, hepatitis, hepatitis and Bikta…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9441
MarketCap: 97,687,525,275.0
High: 78.6 Low: 77.43

Open: 77.91 Close: 78.39 Change: 0.48

Read more →
...
October 14, 2023 15:43 (London Time)

Gilead Sciences

Gilead Sciences Inc. stock rises monday, still underperforms market - marketwatch.com. Gileads Inc. will release third quarter 2023 financial result…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.8885
MarketCap: 96,753,014,510.0
High: 77.86 Low: 76.97

Open: 77.19 Close: 77.65 Change: 0.46

Read more →
...
September 10, 2023 14:01 (London Time)

Gilead Sciences

Gilead Sciences Inc. reported earnings per share of $1.89 for the current quarter. Wall Street analysts predict that Gileads s share price could rea…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9468
MarketCap: 94,697,090,828.0
High: 76.6 Low: 75.05

Open: 76.12 Close: 76.0 Change: -0.12

Read more →
...
September 02, 2023 4:51 (London Time)

Gilead Sciences

Gilead Sciences Inc. stock outperforms competitors on strong trading day - marketwatch.com. gilead sciences inc. stock out outperforms rivals on str…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9921
MarketCap: 95,507,000,157.0
High: 77.41 Low: 76.47

Open: 77.22 Close: 76.65 Change: -0.57

Read more →
...
August 16, 2023 2:48 (London Time)

Gilead Sciences

Gilead Sciences opened a new state-of-the-art facility in Parsippany-Troy Hills on Thursday to serve as the companys East Coast hub. The company is …
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.6808
MarketCap: 99,494,246,087.0
High: 80.21 Low: 78.96

Open: 79.63 Close: 79.64 Change: 0.01

Read more →
...
July 18, 2023 1:36 (London Time)

Gilead Sciences

Gilead Sciences to release second quarter 2023 financial results on thursday, august 3, 2023. FDA approves Veklury for treatment of patients with re…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9783
MarketCap: 96,644,886,343.0
High: 77.76 Low: 76.46

Open: 76.67 Close: 77.48 Change: 0.81

Read more →
...
July 07, 2023 17:10 (London Time)

Gilead Sciences

Gilead Sciences recently released its quarterly earnings report on April 27th. The company generated revenue of $6.35 billion during the same period…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9079
MarketCap: 95,098,169,009.0
High: 75.93 Low: 74.84

Open: 75.66 Close: 75.14 Change: -0.52

Read more →
...
June 05, 2023 22:17 (London Time)

Gilead Sciences

Gilead Sciences (NASDAQ:GILD) Is Paying Out a Larger Dividend than last year. The company has been growing its dividend at a decent rate, and the pa…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9709
MarketCap: 97,156,300,946.0
High: 78.03 Low: 77.18

Open: 77.82 Close: 77.72 Change: -0.1

Read more →
...
June 01, 2023 15:53 (London Time)

Gilead Sciences

Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year. The company has been growing its dividend at a decent rate, and the pa…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.9777
MarketCap: 97,992,960,000.0
High: 77.54 Low: 75.87

Open: 77.54 Close: 76.62 Change: -0.92

Read more →
...
April 28, 2023 1:50 (London Time)

Gilead Sciences

Gilead Sciences Inc. stock underperforms t Tuesday when compared to competitors - marketwatch.inc. The company has 1,247,105,100 shares outstanding.…
Sector: Biotechnology
Ticker: GILD
Sentiment: 0.6808
MarketCap: 104,338,915,328
High: 83.86 Low: 82.42

Open: 83.74 Close: 83.55 Change: -0.19

Read more →